These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 18023092)

  • 21. Small intestine bacterial overgrowth in patients with irritable bowel syndrome.
    Carrara M; Desideri S; Azzurro M; Bulighin GM; Di Piramo D; Lomonaco L; Adamo S
    Eur Rev Med Pharmacol Sci; 2008; 12(3):197-202. PubMed ID: 18700692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.
    Yakoob J; Abbas Z; Khan R; Hamid S; Awan S; Jafri W
    Saudi J Gastroenterol; 2011; 17(6):371-5. PubMed ID: 22064333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
    Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
    Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome].
    Park JS; Yu JH; Lim HC; Kim JH; Yoon YH; Park HJ; Lee SI
    Korean J Gastroenterol; 2010 Oct; 56(4):242-8. PubMed ID: 20962560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.
    Scarpellini E; Giorgio V; Gabrielli M; Filoni S; Vitale G; Tortora A; Ojetti V; Gigante G; Fundarò C; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1314-20. PubMed ID: 23740443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.
    Boltin D; Perets TT; Shporn E; Aizic S; Levy S; Niv Y; Dickman R
    Ann Clin Microbiol Antimicrob; 2014 Oct; 13():49. PubMed ID: 25319626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
    Nucera G; Gabrielli M; Lupascu A; Lauritano EC; Santoliquido A; Cremonini F; Cammarota G; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1391-5. PubMed ID: 15932370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
    Scarpellini E; Giorgio V; Gabrielli M; Lauritano EC; Pantanella A; Fundarò C; Gasbarrini A
    J Pediatr; 2009 Sep; 155(3):416-20. PubMed ID: 19535093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.
    Bae S; Lee KJ; Kim YS; Kim KN
    J Korean Med Sci; 2015 Jun; 30(6):757-62. PubMed ID: 26028929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.
    Ghoshal UC; Srivastava D
    World J Gastroenterol; 2014 Mar; 20(10):2482-91. PubMed ID: 24627585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal bacterial overgrowth as an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhea-predominant irritable bowel syndrome in Asia.
    Wang Y; Xiong L; Gong X; Li W; Zhang X; Chen M
    J Gastroenterol Hepatol; 2015 Jun; 30(6):995-1000. PubMed ID: 25470082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.
    Banik GD; De A; Som S; Jana S; Daschakraborty SB; Chaudhuri S; Pradhan M
    J Breath Res; 2016 May; 10(2):026010. PubMed ID: 27163246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A; Talley NJ; Jones M; Kendall BJ; Koloski N; Walker MM; Morrison M; Holtmann GJ
    Am J Gastroenterol; 2020 Feb; 115(2):190-201. PubMed ID: 31913194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin.
    Vanner S
    Am J Gastroenterol; 2008 Apr; 103(4):964-5. PubMed ID: 18371132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
    Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing.
    Pimentel M; Wallace D; Hallegua D; Chow E; Kong Y; Park S; Lin HC
    Ann Rheum Dis; 2004 Apr; 63(4):450-2. PubMed ID: 15020342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal breath testing in IBS: a meta-analysis.
    Shah ED; Basseri RJ; Chong K; Pimentel M
    Dig Dis Sci; 2010 Sep; 55(9):2441-9. PubMed ID: 20467896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.